 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Methotrexate, Carboplatine |
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT716
NCT00074178
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
50: Requires considerable assistance and frequent medical care |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: Y
Recurrent: N
Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Allowed First relapse of NHL in the CNS, No prior radiotherapy to the CNS, No prior bone marrow transplantation |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
05/01/2007 |
 |
 |
 |
 |
Tumor Types: |
 |
Lymphomas Metastatic Brain Tumor |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
Treatment includes high-dose methotrexate given IV and intra-arterial chemotherapy with carboplatine given inconjunction with blood-brain barrier disruption. After 4 cycles patients in complete response undergo high dose chemotherapy with autologous peripheral stem cell transplantation. No radiotherapy id given to responding patients. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy. |
 |
 |
 |
 |
Contact: |
 |
Cleveland Clinic Brain Tumor and Neuro-Oncology Center Gene Barnett, M.D. Professor and Chairman Brain Tumor Institute R20 9500 Euclid Ave. Cleveland, OH 44195 Phone:216-445-1379 Fax: 216-444-0924 Click here to send an email Website: ccf.org Oregon Health Sciences University Edward Neuwelt, M.D. Professor Contact: Dr. Neuwelt 3181 SW Sam Jackson Park Rd L603 Portland, OR 97239 Phone:(503)494-5626 Fax: (503)494-5627 Click here to send an email Website: www.ohsu.edu/bbb |
 |
 |